Chimeric antigen receptor-natural killer (CAR-NK) cell therapy is a novel immunotherapy
targeting cancer cells via the generation of chimeric antigen receptors on NK cells which …

Recent progress on chimeric antigen receptor (CAR)-NK cells has shown promising results
in treating CD19-positive lymphoid tumors with minimal toxicities [including graft versus host …

Chimeric antigen receptor (CAR)-T adoptive cell therapy is one of the most promising
advanced therapies for the treatment of cancer, with unprecedented outcomes in …

Human endogenous retroviruses (HERV), a type of transposable elements (TE), play crucial
roles in human placental morphogenesis, immune response, and cancer progression …

Cytomegalovirus (CMV) reactivation remains a common complication and leads to high
mortality in patients who undergo allogeneic hematopoietic stem cell transplantation (allo …

Immunotherapy has revolutionized cancer treatment. However, it's well-recognized that a
considerable proportion of patients fail to benefit from immunotherapy, and to improve …

Natural killer (NK) cells hold promise in cancer treatment due to their ability to
spontaneously lyse cancer cells. For clinical use, high quantities of pure, functional NK cells …

Adoptive cell therapy (ACT) with expanded tumor-infiltrating lymphocytes (TIL) or TCR gene-
modified T cells (TCR-T) that recognize mutant KRAS neo-antigens can mediate tumor …

两种扩增体系NK细胞生物学特性比较及治疗异基因造血干细胞移植后白血病复发的初步研究-
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

The presence of peritoneal metastasis in patients with pancreatic cancer is associated with
poor prognosis. Chemotherapy and radiotherapy may result in poor prognosis in patients …